NCT04344119 Assessment of Chilbains Occuring During Covid-19 Infection
| NCT ID | NCT04344119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Skin Manifestations |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2020-04-09 |
| Primary Completion | 2021-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2020-04-09 with a primary completion date of 2021-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Some patients infected by covid-19 develop skin manifestations. These manifestations are still not well known and there pathophysiology remain unclear. Among them, acral manifestation resembling to chilblains appears frequent and quite specific. The aim of this project is to better characterize the cutaneous manifestations occurring during Covid-19 infection with a special focus on chilblains. These acral manifestation could be due to a direct viral effect, but also to microthrombosis or vascularitis. Understanding the pathomechanisms involved could provide interesting clue for understanding not only the skin manifestations but also some of the other systemic symptoms associated to covid-19 infection. This study plan to characterize these acral manifestations by analyzing the clinical and dermoscopic patterns and to correlate them with the non-invasive vascular explorations but also immune and coagulopathy explorations that are done in the CHU of Nice in covid-19 patients.
Eligibility Criteria
Inclusion Criteria: * All patients with proven covid infection (using PCR, serum antibody or lung TDM) and presenting at least one cutaneous lesions that occurred during the infection.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04344119 clinical trial?
This trial is open to participants of all sexes, up to 90 Years, studying Skin Manifestations. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04344119 currently recruiting?
Yes, NCT04344119 is actively recruiting participants. Contact the research team at caillon.c@chu-nice.fr for enrollment information.
Where is the NCT04344119 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT04344119 clinical trial?
NCT04344119 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 30 participants.